Kerala High Court directs Central government to consider compulsory licensing of breast cancer drug Ribociclib

The Court called for emergent action noting that at present, an alarming number of fatalities among breast cancer patients can be attributed to the inability to afford the prohibitively priced drug.
Ernakulam bench of Kerala High Court and Breast cancer
Ernakulam bench of Kerala High Court and Breast cancer

The Kerala High Court recently directed the Department for Promotion of Industry and Internal Trade (DPIIT) under the Union Ministry of Commerce and Industry to consider compulsory licensing of life-saving breast cancer drug, Ribociclib [xxx v. Union of India]

Loading content, please wait...
Bar and Bench - Indian Legal news
www.barandbench.com